Form 4: BiomX Inc. Director Gregory Louis Merril Acquires Options
SEC Form 4 Filing
Director Gregory Louis Merril acquired options to purchase 264,000 shares of BiomX Inc. common stock.
Summary
- On July 11, 2024, Gregory Louis Merril, a director of BiomX Inc., acquired options to purchase 264,000 shares of the company's common stock.
- The exercise price of these options is $0.363 per share.
- The options vest over four years, with 25% vesting on July 11, 2025, and the remainder vesting in 12 equal quarterly installments over three years.
- Following the transaction, Merril directly owns options for 264,000 shares.
Sentiment
Score: 5
Explanation: Neutral sentiment. This is a routine disclosure of stock option grants to a director. It doesn't inherently indicate positive or negative news.
Positives
- A director's acquisition of options may signal confidence in the company's future prospects.
Industry Context
This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership by a company insider. It's common for directors and officers to receive stock options as part of their compensation.
Stakeholder Impact
- The acquisition of options by a director could be viewed positively by shareholders, as it aligns the director's interests with the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 07/11/2024 | Date of options acquisition |
| 07/11/2025 | 25% of options vest |
| 07/11/2034 | Expiration date of options |
| 07/15/2024 | Date of Form 4 signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.